General Information
Revision date
2022-06-15
Product name
Risedronate sodium 2.5-hydrate
CAS No.
329003-65-8
REACH No
is
Icons in SDS
Company Information
company name
Merck Life Science (Pty) Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
Melissa.byrne@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H319, H361, H371
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
2.1 Classification of the substance or mixture
Classification
2.2 Label elements
Labelling
Signal word
Warning Warning
Hazard statements
H302 Harmful if swallowed. H319 Causes serious eye irritation. H361 Suspected of damaging fertility or the unborn child. H371 May cause damage to organs. Reduced Labeling (<= 125 ml) H361 Suspected of damaging fertility or the unborn child.
Precautionary statements
P201 Obtain special instructions before use. P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. Rinse mouth. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P311 IF exposed or concerned: Call a POISON CENTER/ doctor. P201 Obtain special instructions before use.
Supplemental label elements
none none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
